000 01246 a2200373 4500
005 20250512004113.0
264 0 _c19900305
008 199003s 0 0 eng d
022 _a0065-1427
024 7 _a10.1111/j.1600-0404.1989.tb01793.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLees, A J
245 0 0 _aNew approaches in the use of selegiline for the treatment of Parkinson's disease.
_h[electronic resource]
260 _bActa neurologica Scandinavica. Supplementum
_c1989
300 _a139-45 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aDrug Therapy, Combination
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aLevodopa
_xtherapeutic use
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aParkinson Disease
_xdrug therapy
650 0 4 _aPhenethylamines
_xtherapeutic use
650 0 4 _aSelegiline
_xadministration & dosage
700 1 _aFrankel, J
700 1 _aEatough, V
700 1 _aStern, G M
773 0 _tActa neurologica Scandinavica. Supplementum
_gvol. 126
_gp. 139-45
856 4 0 _uhttps://doi.org/10.1111/j.1600-0404.1989.tb01793.x
_zAvailable from publisher's website
999 _c2521707
_d2521707